Procedure safety during chemotherapy

Biopsy During Chemotherapy — Timing Around Your Blood Count Nadir

A biopsy during chemotherapy is not automatically unsafe — but timing matters more than most people realise. Your blood counts drop to their lowest point mid-cycle, and a biopsy at that moment carries real risks of bleeding and infection that a carefully timed biopsy does not.

Medically reviewed by Dr. Mohammed Imaduddin, Surgical Oncologist, MBBS · MS (General Surgery) · M.Ch (Surgical Oncology) · Last reviewed September 2026

Timing, not the treatment itself, is the key question — A biopsy is often safe during chemotherapy — but only if it is scheduled at the right point in your count cycle.
Two teams need to talk — The team ordering the biopsy and the team giving your chemotherapy may not be in contact. You can close that gap with one call.
Counts must be checked, not assumed — Even if you feel well, your blood counts can be at their lowest without any symptoms.
A few days can make a significant difference — Waiting for counts to recover before the procedure reduces the risks considerably.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

A biopsy during chemotherapy can be safe, but timing matters. Your blood counts — particularly platelets and infection-fighting white cells — drop to their lowest point mid-cycle. Most oncologists schedule biopsies after counts have recovered, not at the nadir. Your team will check your results before confirming a date.

If a symptom below applies to you, do not wait for a callback. Call 1800-202-8726 or go to your nearest emergency department.

When should you go to hospital or call your team immediately?

You are bleeding from the biopsy site and it will not stop. Apply firm pressure and go to your nearest emergency department. Do not wait for a callback.
You have a fever after your biopsy. Fever after an invasive procedure during chemotherapy is a same-day emergency. Call your team now or go straight to the emergency department.
The biopsy site is becoming more red, swollen or painful over time. This can signal infection, which spreads quickly when white cell counts are low. Call your team today — do not wait for your next appointment.
You have been told to proceed with a biopsy and no one has checked your current blood counts. Do not go ahead until your oncologist has reviewed your most recent results. Call the chemotherapy team before confirming any procedure date.

What should you confirm before a biopsy during chemotherapy?

Tell both teams — the one ordering the biopsy and the one giving chemotherapy — about each other.
Share your chemotherapy schedule and the date of your last dose with whoever is booking the biopsy.
Ask your oncologist when your counts typically reach their lowest point in your specific regimen.
Confirm a full blood count will be checked within 48 hours of the procedure date.
Ask which count levels must be reached before the biopsy can safely go ahead.
Tell every team involved about all medicines, supplements and traditional remedies you are taking.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Not sure whether this counts as an emergency?

Call the helpline. It is always better to check than to wait.

Book Free Consultation Call 1800 202 8726

When in your cycle is it safe to have a biopsy?

	Usually safe to proceed	Discuss timing with your oncologist first
Day in your cycle	After counts have recovered — typically later in the cycle, before your next dose	Mid-cycle nadir window — the lowest point for your counts
Platelet count	Recovered to the level your team considers safe for the procedure type	Below your team's threshold — raised risk of bleeding during the procedure
Neutrophil count (infection-fighting white cells)	Recovered toward the normal range	At nadir — any skin breach carries a raised infection risk
How recently counts were checked	Full blood count taken within 48 hours of the procedure	Last result more than a few days old — may not reflect where counts are now
Count nadir typically falls	Varies by regimen — your oncologist can tell you the expected window	Often 7–14 days after each treatment dose in many common regimens

Did you know?

Your chemotherapy regimen follows a predictable count pattern, and your oncologist can usually tell you in advance when your nadir is expected.

ASCO supportive care guidance recommends checking a full blood count as close to the procedure date as possible — counts can shift significantly within 48 hours at certain points in the cycle.

Source: ASCO Guidelines on Supportive Care During Systemic Therapy

Questions about biopsy timing that need a longer answer

My biopsy is urgent — what if my counts are currently low?

Urgency changes the calculation, but does not remove it. Your oncologist and the team requesting the biopsy need to decide together whether the result changes your immediate treatment. If it does, the team may proceed with additional precautions. If a few days' delay is clinically safe, they may schedule around your count recovery. Do not cancel or delay without speaking to both teams — urgency is a clinical judgement, not one you should make alone.

My surgeon says it is fine to proceed, but my oncologist is hesitant. Who decides?

Your oncologist should have the final word on timing during active chemotherapy. They know your current count trajectory; the surgeon knows the procedural complexity. When these two teams give you different answers, ask them to speak to each other directly — most disagreements resolve in a brief call. You should not be left to arbitrate between them. If you cannot get them in contact, follow your oncologist's advice on count safety until the teams have aligned.

Does the type of biopsy affect the risk?

Yes. A fine-needle aspiration carries less risk than a core needle biopsy, and a surgical biopsy carries more risk still — from both bleeding and from a wound that needs to heal while your immune system is suppressed. The count levels your team requires will be set higher for a more invasive procedure. Ask specifically which type has been requested and what count levels are needed for that type, because the thresholds differ.

Will low counts affect whether the biopsy result is accurate?

No. Your blood count at the time of the biopsy does not change what the pathologist sees in the tissue sample. The result reflects what is happening in the tissue, not the blood. If a blood-based test has been ordered alongside — such as a liquid biopsy — your team may interpret that differently during active chemotherapy, but tissue biopsies are unaffected by your counts. If you are not sure which type of test has been ordered, ask before the procedure.

Do I need to stop any medicines before a biopsy?

Possibly. Blood thinners — including anticoagulant medicines, antiplatelet medicines and some supplements — raise the risk of bleeding during any invasive procedure. Your oncologist and the team performing the biopsy need to know everything you are taking, including traditional medicines, vitamins and over-the-counter tablets. Do not stop anything on your own; stopping some medicines abruptly carries its own risk. Wait to be told what to pause, for how long, and what to watch for when you restart.

Explore 100 more Preparing For, Having and Recovering From a Biopsy topics

Medication, Blood Thinners & Comorbidity Rules

After the Biopsy: Recovery & Aftercare

Anaesthesia, Sedation & Pain

Biopsy Day: What Happens

Complications & Red Flags

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

Can a biopsy wait until my chemotherapy finishes?

Sometimes, but the reason for the biopsy determines whether waiting is safe. If the result will change your current treatment — confirming a diagnosis or identifying a progression — waiting may not be possible. If the biopsy is planning for a future step and your oncologist is satisfied with your response to treatment, a short delay may be reasonable. Ask directly: does this result change what I am receiving now? That answer should drive the timeline.

What blood tests are needed before a biopsy during chemotherapy?

At minimum, your full blood count — including platelets and neutrophils — should be checked close to the procedure date. Some centres also check your clotting profile. Ask your team when the test needs to be taken and whether it should be repeated if there is any gap before the procedure. The thresholds your team uses vary with the type and location of the biopsy: a superficial biopsy requires less than a deep core needle biopsy.

I have been told to book a biopsy but I am mid-cycle. What should I do first?

Call your oncology team before booking anything. Give them the date of your last chemotherapy dose and the date the biopsy has been requested. They will advise on timing, coordinate with the requesting team if needed, and confirm whether counts need to be checked first. Do not assume the two teams are already in contact — often they are not, and one call from you closes that gap.

Is the gap between chemotherapy cycles always the safest time for a biopsy?

Usually, but between cycles does not automatically mean counts are safe. Counts must be confirmed, not assumed. Some regimens have short recovery windows; some patients recover more slowly than expected. If your counts have reached your team's required level before your next dose, that window is generally preferred for non-urgent procedures. Confirm with a fresh blood count before the date is fixed.

What are the actual risks if a biopsy goes ahead when counts are low?

The two main risks are bleeding and infection. Low platelets slow clotting — minor bleeding from a needle that would settle quickly in someone with normal counts can become significant at nadir. Low neutrophils reduce the body's ability to fight bacteria entering through the biopsy site, so a minor infection can escalate quickly during chemotherapy. Both risks are manageable with careful timing. A few days' wait for a safer count window is almost always worth it.

Full index